<table id="id_22439efa-3dd4-4e41-84fc-1f23b3155d44" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption id="id_aeec42ec-4aed-4e89-9c4e-28a7fa135303">Table 1. Acyclovir Pharmacokinetic Characteristics (Range) </caption>
<col align="left" width="61.500%"></col>
<col align="left" width="38.500%"></col>
<tfoot id="id_11d60471-de62-40e8-84f5-6787039df570">
<tr>
<td align="left" colspan="2" stylecode="Lrule Botrule Rrule" valign="top">
<paragraph>* Bioavailability decreases with increasing dose. </paragraph>
</td>
</tr>
</tfoot>
<tbody>
<tr id="id_ab64ae09-b5a6-48e7-aafa-7077947a2813">
<td align="center" stylecode="Botrule Toprule Rrule Lrule" valign="top">Parameter </td>
<td align="center" stylecode="Botrule Rrule" valign="top">Range </td>
</tr>
<tr id="id_4cf6130a-9cde-4fee-ae24-deed08f56a4c">
<td align="left" stylecode="Lrule Botrule Rrule" valign="top">Plasma protein binding </td>
<td align="center" stylecode="Botrule Rrule" valign="top">9% to 33% </td>
</tr>
<tr id="id_536158b6-af50-454b-b2dc-d9f014a65f06">
<td align="left" stylecode="Lrule Botrule Rrule" valign="top">Plasma elimination half-life </td>
<td align="center" stylecode="Botrule Rrule" valign="top">2.5 to 3.3 h </td>
</tr>
<tr id="id_7113a9b5-5444-4715-a34d-d6c5127bb907">
<td align="left" stylecode="Lrule Botrule Rrule" valign="top">Average oral bioavailability </td>
<td align="center" stylecode="Botrule Rrule" valign="top">10% to 20%* </td>
</tr>
</tbody>
</table>